Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsRent ExpenseShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesWages, Salaries and Other
Ratios

Acadia Healthcare Company (ACHC) Shares Repurchased (2021 - 2026)

Acadia Healthcare Company (ACHC) has disclosed Shares Repurchased for 6 consecutive years, with -$2.7 million as the latest value for Q1 2026.

  • For Q1 2026, Shares Repurchased fell 105.85% year-over-year to -$2.7 million; the TTM value through Mar 2026 reached $410000.0, down 99.12%, while the annual FY2025 figure was $50.0 million, 3831.1% up from the prior year.
  • Shares Repurchased hit -$2.7 million in Q1 2026 for Acadia Healthcare Company, down from $3.2 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $46.9 million in Q1 2025 and bottomed at -$47.7 million in Q1 2023.
  • Average Shares Repurchased over 5 years is -$304333.3, with a median of $844000.0 recorded in 2024.
  • Year-over-year, Shares Repurchased plummeted 306.02% in 2023 and then soared 4727.84% in 2025.
  • Acadia Healthcare Company's Shares Repurchased stood at $1.4 million in 2022, then crashed by 37.0% to $858000.0 in 2023, then tumbled by 160.26% to -$517000.0 in 2024, then surged by 710.06% to $3.2 million in 2025, then plummeted by 187.0% to -$2.7 million in 2026.
  • According to Business Quant data, Shares Repurchased over the past three periods came in at -$2.7 million, $3.2 million, and $46.9 million for Q1 2026, Q2 2025, and Q1 2025 respectively.